FindTrial
Sign In

Comparing the effect of cognitive rehabilitation intervention with transcranial magnetic stimulation (rTMS) on craving and executive functions and its effect on quantitative QEEG indices in people with cannabis use disorder

Comparing the effect of cognitive rehabilitation intervention with transcranial magnetic stimulation (rTMS) on craving and executive functions and its effect on quantitative QEEG indices in people with cannabis use disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250911067211N1
Enrollment
60
Registered
2025-10-14
Start date
2024-04-21
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cannabis use disorder. Cannabis abuse

Interventions

Intervention 1: Intervention group one: Cognitive rehabilitation. Intervention 2: Second intervention group: rTMS transcranial magnetic stimulation. Intervention 3: Control group: No intervention.

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
22 Years to 35 Years

Inclusion criteria

Inclusion criteria: Having a diagnosis of cannabis use disorder Being in the age range of 20 to 35 years Consuming cannabis at least three times a week Diploma and higher education

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Cannabis craving. Timepoint: At the beginning of the study (before the start of the intervention), 12 and 16 weeks after the start of the intervention. Method of measurement: Craving with the Craving Questionnaire of Franken et al. (2002).;Executive functions. Timepoint: At the beginning of the study (before the start of the intervention), 12 and 16 weeks after the start of the intervention. Method of measurement: CANTab.;Quantitative QEEG indicators. Timepoint: At the beginning of the study (before the start of the intervention), 12 and 16 weeks after the start of the intervention. Method of measurement: QEEG device.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarahnaz Mohammad Qezel Ayagh

Iran University of Medical Sciences

farahnazghezelayagh@gmail.com+98 21 2255 0942

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026